Mylan Says It Would Settle for 50% of Perrigo

Drugmaker lowers support level needed for hostile takeover.

comments Print
Mylan, which is trying to buy drug maker Perrigo through a $34 billion hostile tender offer, on Thursday lowered the level of support it will require from Perrigo shareholders to push through the takeover.